Abstract
Cancer and inflammation related anemia is mediated by proinflammatory cytokines. However, the molecular mechanism of this cytokines‐inhibited erythropoiesis remains unclear. This study shows that proinflammatory cytokines, TNF‐α and IFN‐γ, inhibit activin A‐activated ζ‐globin promoter, but not IL‐1α, IL‐10 and IL‐13 in hematopoieticprogenitor cell line K562. The p38 inhibitor SB203580 decreases activin A‐activated ζ‐globin promoter, but did not alter the effects of TNF‐α and IFN‐γ. The NF‐κB inhibitor Bay117082 reduces TNF‐α‐ and IFN‐γ‐inhibited ζ‐globin promoter activity, but did not alter the effects of activin A. Activin A inhibits c‐Jun expression, c‐Jun binding to AP‐1 binding sites of c‐Jun promoter and c‐Jun promoter activity through p38 pathway. TNF‐α induces c‐Jun expression to reverse activin A inhibitory effects via NF‐κB/c‐Jun complex binding to AP‐1 bonding sites of c‐Jun promoter. Furthermore, wild‐type c‐Jun enhances and c‐Jun dominant negative mutant eliminates TNF‐α‐inhibited ζ‐globin promoter activity. Thus, activin A down‐regulates c‐Jun through p38 to induce globin gene expression. TNF‐α activates NF‐κB/c‐Jun to inhibit the effects of activin A on hematopoieticprogenitor cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.